P

Inventor

MORGANS JR DAVID J

US77 patents
⚠️ This page may combine multiple inventors who share the name “MORGANS JR DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CYTOKINETICS INC

29 patents
US7507735B2Mar 24, 2009

Compounds, compositions and methods

CYTOKINETICS INC72 citations99
US10975034B2Apr 13, 2021

Compounds, compositions and methods

CYTOKINETICS INC23 citations98
US10385023B2Aug 20, 2019

Compounds, compositions and methods

CYTOKINETICS INC23 citations98
US10035770B2Jul 31, 2018

Compounds, compositions and methods

CYTOKINETICS INC25 citations98
US9643925B2May 9, 2017

Compounds, compositions and methods

CYTOKINETICS INC26 citations98
US9150564B2Oct 6, 2015

Compounds, compositions and methods

CYTOKINETICS INC28 citations98
US7888373B2Feb 15, 2011

Heterocyclic sulfonamides as modulators of cardiac sarcomeres

CYTOKINETICS INC40 citations96
US7595322B2Sep 29, 2009

Heterocyclic sulfonamides as modulators of cardiac sarcomeres

CYTOKINETICS INC41 citations96
US7718657B2May 18, 2010

Certain indanyl urea modulators of the cardiac sarcomere

CYTOKINETICS INC20 citations92
US7598248B2Oct 6, 2009

Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols, compositions thereof, and methods for their use

CYTOKINETICS INC17 citations92
US7528137B2May 5, 2009

Compounds, compositions, and methods

CYTOKINETICS INC19 citations92
US7491826B2Feb 17, 2009

Compounds, compositions and methods

CYTOKINETICS INC27 citations92
US7399866B2Jul 15, 2008

Compounds, compositions, and methods

CYTOKINETICS INC29 citations92
US7332498B2Feb 19, 2008

Modulation of KSP kinesin activity with heterocyclic-fused pyrimidinone derivatives

CYTOKINETICS INC19 citations92
US7208487B2Apr 24, 2007

Compounds, compositions and methods

CYTOKINETICS INC39 citations92
US7538223B2May 26, 2009

Compounds, compositions and methods

CYTOKINETICS INC26 citations91
US7989455B2Aug 2, 2011

Compounds, compositions and methods

CYTOKINETICS INC9 citations84
US7956056B2Jun 7, 2011

Certain 1H-imidazo[4,5-B]pyrazin-2(3H)-ones and 1H-imidazo[4,5-B]pyrazin-2-ols, compositions thereof, and methods for their use

CYTOKINETICS INC10 citations84
US7939548B2May 10, 2011

Certain chemical entities, compositions, and methods

CYTOKINETICS INC7 citations84
US7825120B2Nov 2, 2010

Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas

CYTOKINETICS INC12 citations84
US7851484B2Dec 14, 2010

Certain chemical entities, compositions, and methods

CYTOKINETICS INC14 citations81
US12264133B2Apr 1, 2025

Compounds, compositions and methods

CYTOKINETICS INC1 citations75
US10766899B2Sep 8, 2020

Methods for preparing substituted imidazo[4,5-b]pyrazines

CYTOKINETICS INC2 citations73
US7629477B2Dec 8, 2009

Compounds, compositions and methods

CYTOKINETICS INC5 citations73
US7582668B2Sep 1, 2009

Imidazoyl-benzamide anti-cancer agents

CYTOKINETICS INC5 citations73
US7491746B2Feb 17, 2009

Compounds, compositions and methods

CYTOKINETICS INC5 citations73
US7618981B2Nov 17, 2009

Imidazopyridinyl-benzamide anti-cancer agents

CYTOKINETICS INC7 citations72
US7482343B2Jan 27, 2009

Compounds, methods and compositions

CYTOKINETICS INC3 citations63
US7271167B2Sep 18, 2007

Compounds, compositions, and methods

CYTOKINETICS INC3 citations63

SMITHKLINE BEECHAM CORP

6 patents
US7041676B2May 9, 2006

Compounds, compositions, and methods

SMITHKLINE BEECHAM CORP87 citations98
US7214800B2May 8, 2007

Compounds, compositions, and methods

SMITHKLINE BEECHAM CORP21 citations92
US7166595B2Jan 23, 2007

Compounds, methods and compositions

SMITHKLINE BEECHAM CORP25 citations92
US7038048B2May 2, 2006

3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use

SMITHKLINE BEECHAM CORP32 citations92
US6924376B2Aug 2, 2005

Compounds, compositions and methods

SMITHKLINE BEECHAM CORP22 citations92
US6949538B2Sep 27, 2005

Compounds, compositions, and methods

SMITHKLINE BEECHAM CORP4 citations63

MORGAN BRADLEY PAUL

5 patents
US8101620B2Jan 24, 2012

Heterocyclic sulfonamides

MORGAN BRADLEY PAUL40 citations97
US8513257B2Aug 20, 2013

Ureas and their use in the treatment of heart failure

MORGAN BRADLEY PAUL30 citations96
US8110595B2Feb 7, 2012

Ureas and their use in the treatment of heart failure

MORGAN BRADLEY PAUL37 citations96
US8101617B2Jan 24, 2012

Disubstituted ureas and uses thereof in treating heart failure

MORGAN BRADLEY PAUL28 citations96
US8604025B2Dec 10, 2013

Heterocyclic sulfonamides

MORGAN BRADLEY PAUL3 citations73

QIAN XIANGPING

3 patents
US8088793B2Jan 3, 2012

Certain chemical entities, compositions, and methods

QIAN XIANGPING20 citations91
US8071625B2Dec 6, 2011

Certain chemical entities, compositions, and methods

QIAN XIANGPING2 citations62
US8063082B2Nov 22, 2011

Certain chemical entities, compositions, and methods

QIAN XIANGPING2 citations62

PLIANT THERAPEUTICS INC

2 patents
US10793564B2Oct 6, 2020

Amino acid compounds and methods of use

PLIANT THERAPEUTICS INC25 citations93
US11180494B2Nov 23, 2021

Substituted amino acids as integrin inhibitors

PLIANT THERAPEUTICS INC11 citations84

MORGAN BRADLEY P

2 patents
US8445495B2May 21, 2013

Certain Chemical entities, compositions and methods

MORGAN BRADLEY P25 citations91
US8410108B2Apr 2, 2013

Certain chemical entities, compositions and methods

MORGAN BRADLEY P5 citations82

SYNTEX INC

1 patent
US5859014AJan 12, 1999

Pyrimidinedione, pyrimidinetrione, triazinedione and tetrahydroquinazolinedione derivatives as α1 -adrenergic receptor antagonists

SYNTEX INC50 citations90

ICONIX PHARM INC

1 patent
US7054755B2May 30, 2006

Interactive correlation of compound information and genomic information

ICONIX PHARM INC29 citations86

MUCI ALEX

1 patent
US8293761B2Oct 23, 2012

Certain chemical entities, compositions and methods

MUCI ALEX5 citations68

Showing the top 50 of 77 patents by PatentIndex Score.